Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Amrubicin

First report of interstitial lung disease: 7 patients

    • 10 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Yoh K, Kenmotsu H, Yamaguchi Y, Kubota K, Ohmatsu H, Goto K, Niho S, Ohe Y, Saijo N, Nishiwaki Y.Severe interstitial lung disease associated with amrubicin treatment. Journal of Thoracic Oncology 5: 1435-1438, No. 9, Sep 2010. Available from: URL: http://dx.doi.org/10.1097/jto.0b013e3181e369a8 - Japan

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Amrubicin. React. Wkly. 1324, 11 (2010). https://doi.org/10.2165/00128415-201013240-00027

    Download citation

    Keywords

    • Lung Cancer
    • Cell Lung Cancer
    • Respiratory Failure
    • Methylprednisolone
    • Small Cell Lung Cancer